Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Sir_Holleron Jul 07, 2015 10:23am
96 Views
Post# 23898140

RE:Kilmer Lucas one month tomorrow

RE:Kilmer Lucas one month tomorrow

Compare what Stephen Kilmer quote from 2009 in this news release to the quote in BTI's news release and get a laugh. This is really inspired corporate communications: 
 

"Stephen Kilmer, President of Kilmer Lucas, commented, "We believe that a great investment story is emerging at Stellar and we are excited that the Company has chosen us to help tell it. Through the provision of a full range of investor relations and corporate communications services, our primary goals will be to help Stellar achieve a fair and sustainable market valuation and to enhance the reputation that the Company carries in the minds of investors, analysts and members of the media."" https://www.marketwired.com/press-release/Stellar-Pharmaceuticals-Retains-Kilmer-Lucas-for-Investor-Communications-1038110.htm

 

-----

Stephen Kilmer, President of Kilmer Lucas, commented, "We believe that a strong investment story is emerging at biOasis and we are excited that the company has chosen us to help tell it. Through the provision of a full range of investor relations and financial communications services, our primary goals will be to assist biOasis in achieving a fair and sustainable market valuation and to enhance the reputation that the company carries in the minds of investors, analysts and members of the media."Read more at https://www.stockhouse.com/news/press-releases/2015/06/08/bioasis-engages-kilmer-lucas-for-cross-border-investor-relations#LUMv8fMgYfYCHRqx.99




 

 

Bullboard Posts